PP
MRSN

PDT Partners’s Mersana Therapeutics MRSN Stock Holding History

PDT Partners’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-999
Closed -$169K – 798
2022
Q3 		$169K Sell
999
-8,677
-90% -$1.41M 0.03% 741
2022
Q2 		$1.12M Sell
9,676
-3,381
-26% -$318K 0.1% 357
2022
Q1 		$1.3M Buy
13,057
+8,590
+192% +$1M 0.11% 290
2021
Q4 		$695K Buy
4,467
+3,247
+266% +$632K 0.05% 447
2021
Q3 		$288K Buy
+1,220
New +$356K 0.02% 605

Other funds holding MRSN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return